Skip to content

Clinical trials

Completed Hepatitis B, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B, Chronic Status: Completed Country / region: Germany Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20053
20063
20072
20082
20092
20102
20115
20122
20131
20142
20151
20181
20192
20203
20211
20224
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences8
Hoffmann-La Roche6
Novartis Pharmaceuticals5
Bristol-Myers Squibb4
GlaxoSmithKline4
Janssen Sciences Ireland UC3
Janssen Research & Development, LLC2
Transgene2
Vir Biotechnology, Inc.2
Hologic, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic39
Hepatitis B11
Hepatitis6
Hepatitis, Chronic2
Fibrosis1
HIV Seropositivity1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.